Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad.

Matsubara D, Kanai Y, Ishikawa S, Ohara S, Yoshimoto T, Sakatani T, Oguni S, Tamura T, Kataoka H, Endo S, Murakami Y, Aburatani H, Fukayama M, Niki T.

J Thorac Oncol. 2012 Dec;7(12):1872-6. doi: 10.1097/JTO.0b013e3182721ed1.

PMID:
23154560
[PubMed - indexed for MEDLINE]
2.

Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.

Suzuki M, Makinoshima H, Matsumoto S, Suzuki A, Mimaki S, Matsushima K, Yoh K, Goto K, Suzuki Y, Ishii G, Ochiai A, Tsuta K, Shibata T, Kohno T, Esumi H, Tsuchihara K.

Cancer Sci. 2013 Jul;104(7):896-903. doi: 10.1111/cas.12175. Epub 2013 May 12.

PMID:
23578175
[PubMed - indexed for MEDLINE]
3.

RET, ROS1 and ALK fusions in lung cancer.

Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y.

Nat Med. 2012 Feb 12;18(3):378-81. doi: 10.1038/nm.2658.

PMID:
22327623
[PubMed - indexed for MEDLINE]
4.

RET fusion genes in Korean non-small cell lung cancer.

Yoo SS, Jin G, Jung HJ, Hong MJ, Choi JE, Jeon HS, Lee SY, Lim JO, Park JY.

J Korean Med Sci. 2013 Oct;28(10):1555-8. doi: 10.3346/jkms.2013.28.10.1555. Epub 2013 Sep 25.

PMID:
24133367
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.

Wang R, Hu H, Pan Y, Li Y, Ye T, Li C, Luo X, Wang L, Li H, Zhang Y, Li F, Lu Y, Lu Q, Xu J, Garfield D, Shen L, Ji H, Pao W, Sun Y, Chen H.

J Clin Oncol. 2012 Dec 10;30(35):4352-9. doi: 10.1200/JCO.2012.44.1477. Epub 2012 Nov 13.

PMID:
23150706
[PubMed - indexed for MEDLINE]
Free Article
6.

KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.

Yokota K, Sasaki H, Okuda K, Shimizu S, Shitara M, Hikosaka Y, Moriyama S, Yano M, Fujii Y.

Oncol Rep. 2012 Oct;28(4):1187-92. doi: 10.3892/or.2012.1908. Epub 2012 Jul 13.

PMID:
22797671
[PubMed - indexed for MEDLINE]
7.

KIF5B-RET fusions in Chinese patients with non-small cell lung cancer.

Cai W, Su C, Li X, Fan L, Zheng L, Fei K, Zhou C.

Cancer. 2013 Apr 15;119(8):1486-94. doi: 10.1002/cncr.27940. Epub 2013 Feb 1.

PMID:
23378251
[PubMed - indexed for MEDLINE]
8.

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.

Tsuta K, Kohno T, Yoshida A, Shimada Y, Asamura H, Furuta K, Kushima R.

Br J Cancer. 2014 Mar 18;110(6):1571-8. doi: 10.1038/bjc.2014.36. Epub 2014 Feb 6.

PMID:
24504365
[PubMed - indexed for MEDLINE]
9.

KIF5B-RET fusions in lung adenocarcinoma.

Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, Sakamoto H, Tsuta K, Furuta K, Shimada Y, Iwakawa R, Ogiwara H, Oike T, Enari M, Schetter AJ, Okayama H, Haugen A, Skaug V, Chiku S, Yamanaka I, Arai Y, Watanabe S, Sekine I, Ogawa S, Harris CC, Tsuda H, Yoshida T, Yokota J, Shibata T.

Nat Med. 2012 Feb 12;18(3):375-7. doi: 10.1038/nm.2644.

PMID:
22327624
[PubMed - indexed for MEDLINE]
10.

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.

Suehara Y, Arcila M, Wang L, Hasanovic A, Ang D, Ito T, Kimura Y, Drilon A, Guha U, Rusch V, Kris MG, Zakowski MF, Rizvi N, Khanin R, Ladanyi M.

Clin Cancer Res. 2012 Dec 15;18(24):6599-608. doi: 10.1158/1078-0432.CCR-12-0838. Epub 2012 Oct 10.

PMID:
23052255
[PubMed - indexed for MEDLINE]
Free Article
11.

[The progress of KIF5B-RET fusion gene in non-small cell lung cancer].

Jin LL, Kong H, Xie WP.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jul;36(7):524-6. Review. Chinese. No abstract available.

PMID:
24262090
[PubMed - indexed for MEDLINE]
12.

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.

Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M, Chang H, Motohashi S, Yokoi S, Hiroshima K, Tagawa M, Nakayama T, Fujisawa T.

Cancer Immunol Immunother. 2004 Sep;53(9):786-92. Epub 2004 Jun 4.

PMID:
15185009
[PubMed - indexed for MEDLINE]
13.

Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.

Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z.

Clin Cancer Res. 2008 Oct 15;14(20):6432-9. doi: 10.1158/1078-0432.CCR-07-4401.

PMID:
18927282
[PubMed - indexed for MEDLINE]
Free Article
14.

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models.

Okamoto K, Kodama K, Takase K, Sugi NH, Yamamoto Y, Iwata M, Tsuruoka A.

Cancer Lett. 2013 Oct 28;340(1):97-103. doi: 10.1016/j.canlet.2013.07.007. Epub 2013 Jul 12.

PMID:
23856031
[PubMed - indexed for MEDLINE]
Free Article
15.

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.

Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T.

J Thorac Oncol. 2011 Jul;6(7):1152-61. doi: 10.1097/JTO.0b013e318216ee52.

PMID:
21597390
[PubMed - indexed for MEDLINE]
16.

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, Curran JA, Balasubramanian S, Bloom T, Brennan KW, Donahue A, Downing SR, Frampton GM, Garcia L, Juhn F, Mitchell KC, White E, White J, Zwirko Z, Peretz T, Nechushtan H, Soussan-Gutman L, Kim J, Sasaki H, Kim HR, Park SI, Ercan D, Sheehan CE, Ross JS, Cronin MT, Jänne PA, Stephens PJ.

Nat Med. 2012 Feb 12;18(3):382-4. doi: 10.1038/nm.2673.

PMID:
22327622
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

RET fusion gene: translation to personalized lung cancer therapy.

Kohno T, Tsuta K, Tsuchihara K, Nakaoku T, Yoh K, Goto K.

Cancer Sci. 2013 Nov;104(11):1396-400. doi: 10.1111/cas.12275. Epub 2013 Oct 1. Review.

PMID:
23991695
[PubMed - indexed for MEDLINE]
18.

Mouse model for ROS1-rearranged lung cancer.

Arai Y, Totoki Y, Takahashi H, Nakamura H, Hama N, Kohno T, Tsuta K, Yoshida A, Asamura H, Mutoh M, Hosoda F, Tsuda H, Shibata T.

PLoS One. 2013;8(2):e56010. doi: 10.1371/journal.pone.0056010. Epub 2013 Feb 13.

PMID:
23418494
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Novel targets in non-small cell lung cancer: ROS1 and RET fusions.

Gainor JF, Shaw AT.

Oncologist. 2013;18(7):865-75. doi: 10.1634/theoncologist.2013-0095. Epub 2013 Jun 28. Review.

PMID:
23814043
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

Ju YS, Lee WC, Shin JY, Lee S, Bleazard T, Won JK, Kim YT, Kim JI, Kang JH, Seo JS.

Genome Res. 2012 Mar;22(3):436-45. doi: 10.1101/gr.133645.111. Epub 2011 Dec 22.

PMID:
22194472
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk